Quris
Boston, US · 5 known investors
Find your way into Quris
52 people in our graph share verified history with the Quris team — schools, employers, funds. One of them is your warm intro.
Avantika Guptaunlockedknows Isaac Bentwich · together at UniServices (overlapped)
×4knows the team · via Ben-Gurion University of the Negev
×4knows the team · via Technion
knows the team · via CropX LTD
×2knows the team · via UniServices
Quris develops a machine-learning platform for drug development, applying AI, engineering, and biology to predict how drugs will perform. The company works in the pharmaceutical and biotech space to improve how new drugs are tested and developed.
Founders & leadership
IB
Isaac BentwichinFounder & CEOIsaac Bentwich is founder and CEO of Quris, which develops machine-learning tools for pharmaceutical drug development.
YH
Yossi HaraninCo-Founder & CTO
Investors · 5
Funding
SEC filings, press & company announcements$28M disclosed across 1 of 3 rounds · 2021–2022
- Undisclosed amountSeed FundingDec 2022Source ↗
- $28MSeed FundingJan 2022 · 3 sourcesSource ↗
- Undisclosed amountseed fundingOct 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 5
by search overlap
Quralis8 shared keywordsQurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms. The company was founded by neuroscientists from Harvard to translate emerging discoveries about disease pathways into treatment breakthroughs for ALS patients.
Qureator5 shared keywordsQureator develops non-animal testing methods for drug development, notably achieving an FDA IND approval without animal proof-of-concept data in collaboration with SillaJen. The company works in preclinical biotech, providing alternatives to animal testing for pharmaceutical partners.
Recursion (NASDAQ: RXRX)4 shared keywordsRecursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.
Accuristech4 shared keywordsAccuris provides a searchable library of over 2.8 million engineering standards, regulations, and parts data, delivered through two platforms for engineering and supply chain intelligence. Its tools help engineers and supply chain teams maintain compliance, trace requirements, and manage component obsolescence risks across regulated industries such as aerospace, energy, automotive, medical devices, and government.
Curi Bio4 shared keywordsCuri Bio provides a preclinical drug development platform combining 3D human tissue models of disease (cardiac and skeletal muscle), biosystems for functional analysis, and AI/ML-based insights to assess drug safety, efficacy, and potency. It serves pharmaceutical and biotech R&D teams working on drug discovery.
Companies competing with Quris for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Quris do?
- Quris develops a machine-learning platform for drug development, applying AI, engineering, and biology to predict how drugs will perform. The company works in the pharmaceutical and biotech space to improve how new drugs are tested and developed.
- Who founded Quris?
- Quris was founded by Isaac Bentwich, Yossi Haran.
- Who are Quris's investors?
- Quris's investors include Fusion VC, SoftBank Vision Fund, Vox Capital, Welltech Ventures, iAngels.
- How much funding has Quris raised?
- Quris has disclosed $28M raised across 1 of its 3 known rounds.
- Where is Quris headquartered?
- Quris is headquartered in Boston, US.